Mirador Capital Partners LP Axsome Therapeutics, Inc. Transaction History
Mirador Capital Partners LP
- $529 Million
- Q4 2024
A detailed history of Mirador Capital Partners LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 4,000 shares of AXSM stock, worth $474,120. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$474,120
Previous $359,000
5.85%
% of portfolio
0.06%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
35.7MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$480 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$391 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$174 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$165 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.08B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...